We are live on
!
Find out more
ABMD
Abiomed Inc
ABMD
ABMD
Delisted
ABMD was delisted on the 21st of December, 2022.
529 hedge funds and large institutions have $12.8B invested in Abiomed Inc in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 198 increasing their positions, 179 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
11% more repeat investments, than reductions
Existing positions increased: 198 | Existing positions reduced: 179
9% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 75
0% more funds holding
Funds holding: 529 → 529 (0)
28% less capital invested
Capital invested by funds: $17.9B → $12.8B (-$5.09B)
35% less funds holding in top 10
Funds holding in top 10: 20 → 13 (-7)
37% less call options, than puts
Call options by funds: $143M | Put options by funds: $227M
Holders
529
Holders Change
–
Holders Change %
0%
% of All Funds
11.79%
Holding in Top 10
13
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-35%
% of All Funds
0.29%
New
82
Increased
198
Reduced
179
Closed
75
Calls
$143M
Puts
$227M
Net Calls
-$84M
Net Calls Change
+$88.9M
Top Buyers
Top Sellers
| 1 |
MWNA
Marshall Wace North America
New York
|
-$177M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$163M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$146M |
| 4 |
Two Sigma Advisers
New York
|
-$79.7M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$79.3M |
